Revenue: US$10.5m (down 6.7% from 1H 2024).
Net loss: US$4.69m (loss narrowed by 20% from 1H 2024).
US$0.016 loss per share (improved from US$0.02 loss in 1H 2024).
ASX:NXS Earnings and Revenue History September 1st 2025
All figures shown in the chart above are for the trailing 12 month (TTM) period
Next Science’s share price is broadly unchanged from a week ago.
We should say that we’ve discovered 5 warning signs for Next Science (4 are concerning!) that you should be aware of before investing here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.